Novel Models to Identify Census Tracts for Hepatitis C Screening Interventions.

Ludden, Thomas; Shade, Lindsay; Thomas, Jeremy; de Hernandez, Brisa Urquieta; Mohanan, Sveta; Russo, Mark W; Leonard, Michael; Zamor, Philippe J et al. · J Am Board Fam Med · 2020

cross_sectional · Level IV

Where this comes from

Abstract

Increased screening efforts and the development of effective antiviral treatments have led to marked improvement in hepatitis C (HCV) patient outcomes. However, many people in the United States are still believed to have undiagnosed HCV. Geospatial modeling using variables representing at-risk populations in need of screening for HCV and social determinants of health (SDOH) provide opportunities to identify populations at risk of HCV. A literature review was conducted to identify variables associated with patients at risk for HCV infection. Two sets of variables were collected: HCV Transmission Risk and SDOH Level of Need. The variables were combined into indices for each group and then mapped at the census tract level (n = 233). Multiple linear regression analysis and the Pearson correlation coefficient were used to validate the models. A total of 4 HCV Transmission Risk variables and 12 SDOH Level of Need variables were identified. Between the 2 indexes, 21 high-risk census tracts were identified that scored at least 2 standard deviations above the mean. The regression analysis showed a significant relationship with HCV infection rate and prevalence of drug use (B = 0.78, <i>P</i> < .001). A significant relationship also existed with the HCV infection rate for households with no/limited English use (B = -0.24, <i>P</i> = .001), no car use (B = 0.036, <i>P</i> < .001), living below the poverty line (B = 0.014, <i>P</i> = .009), and median household income (B = -0.00, <i>P</i> = .009). Geospatial models identified high-priority census tracts that can be used to map high-risk HCV populations that may otherwise be unrecognized. This will allow future targeted screening and linkage-to-care interventions for patients at high risk of HCV.

Medical subject headings